close read more

About Servier

Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2021, Servier employs 21,800 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities.

A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neuroscience and immuno-inflammatory diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.

Press contact : – presse@servier.com

Press release

Press release
Servier partners with BioLabs Global to open an incubator in Paris-Saclay for early stage life science companies
Press release
Servier and PRISM BioLab enter drug discovery collaboration for a novel target
Press release
Servier and Oncodesign announce the selection of a preclinical candidate as part of their collaboration targeting new treatments for Parkinson’s disease
Press release
Servier appoints Bertrand Renaud as Chief Patient Officer
Press release
The Campus Biotech Digital joins forces with Atos, IBM and Microsoft to develop a unique training platform
Press release
Béatrice Bihr joins the Servier Group as Executive Vice President General Secretariat and member of the Group Executive Committee
Press release
Servier is launching, with the endorsement of the International Society of Hypertension, the third edition of “Because I say so” a public campaign to raise awareness of the importance of blood pressure measurement
Press release
Servier together with World Heart Federation and Global Heart Hub, launches “Use Heart to Act Now on Angina,” a public campaign to raise awareness on angina
Press release
Mediator Trial – Les Laboratoires Servier acknowledge the appeal by the Paris Prosecutor’s Office in the Mediator case